HCV-IN-41

• UNSPSC Description:

  HCV-IN-41 (compound 4) is a highly potent hepatitis C virus (HCV) inhibitor with an EC50 value of 0.006762 nM, 5.183 nM, 1.365 nM and 142.2 nM for HCV genotype 1b, 2a, 3a and 4a, respectively. HCV-IN-41 reduces HCV RNA replication[1].

• Target Antigen:

  HCV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/hcv-in-41.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC(COC(N[C@H](C1=CC=CC=C1)C(N2CCC[C@H]2C(NC3=CC=C(C=C3)C4=CC=C(C=C4)NC([C@@H]5CCCN5C([C@@H](C6=CC=CC=C6)NC(OCC(C)C)=O)=O)=O)=O)=O)=O)C

• Molecular Weight:

  844.99

• References & Citations:

  [1]Abdel Karim SE, et al. Symmetric benzidine derivatives as anti-HCV agents: Insight into the nature, stereochemistry of the capping amino acid and the size of the terminal capping carbamates. Bioorg Chem. 2020 Sep;102:104089.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2468169-71-1